From: Determinants of new drugs prescription in the Swiss healthcare market
Variable | Nature of the contrast | Contrast (years) |
---|---|---|
Prescription level | ||
Rx | Yes - No | −12.6 [−14.1; −11.1] |
Generic drug | Yes - No | −15.2 [−17.0; −13.4] |
Market level | ||
Number of insured | 100,000 - 10,000 | −5.5 [−6.1; −4.8] |
Treatment cost | 1000 CHF - 500 CHF | −1.8 [−2.0; −1.6] |
Herfindahl-Hirschman index | 1 – 0.5 | 11.6 [10.2; 12.9] |
Number of drugs | 50 - 1 | −6.1 [−6.5; −5.7] |
Number of active substances | 5 - 1 | −6.5 [−7.2; −5.9] |
Patient level | ||
Age | (85+) - (0-19) | 0.43 [0.38; 0.48] |
Male | Male - Female | −0.16 [−0.18; −0.14] |
Deductible | (>400 CHF) - (<=400 CHF) | 0.24 [0.21; 0.27] |
Co-morbidity index | 10 - 1 illnesses | −0.024 [−0.027; −0.021] |
Physician level | ||
Physician’s specialty | Hospital specialist – GP | 1.03 [0.91; 1.15] |
Region level | ||
Canton | Jura - Neuchâtel | 2.78 [2.46; 3.10] |